See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2020_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 36,149,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,575,000 |
| 2 | PropertyPlantAndEquipmentNet | 4,350,000 |
| 3 | remainder_Assets | 183,000 |
| 4 | LiabilitiesCurrent | 4,521,000 |
| 5 | LiabilitiesNoncurrent | 1,205,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,995,942 |
| 9 | ResearchAndDevelopmentExpense | 26,069,057 |
| 10 | remainder_Expenses | 1,269,954 |
| 11 | remainder_Revenues | 9,187,556 |
| 12 | remainder_NetIncome | 2,882,688 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 45,257,000 |
| 1 | Liabilities | 5,726,000 |
| 2 | Expenses | 41,334,953 |
| 3 | Revenues | 9,187,556 |
| 4 | StockholdersEquity | 39,531,000 |
| 5 | NetIncome | -29,264,709 |
| 6 | ComprehensiveNetIncome | -29,264,709 |
| 7 | BaseVar | 52,194,098 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.23 |
| 9 | EconomicCapitalRatio | 3.18 |
Edgar->Model Mapping
Feature Distribution
Change over Time
